170 related articles for article (PubMed ID: 38332909)
1. Serum S100A8/A9 and MMP-9 levels are elevated in systemic lupus erythematosus patients with cognitive impairment.
Muñoz-Grajales C; Barraclough ML; Diaz-Martinez JP; Su J; Bingham K; Kakvan M; Kretzmann RP; Tartaglia MC; Ruttan L; Choi MY; Appenzeller S; Marzouk S; Bonilla D; Katz P; Beaton D; Green R; Gladman DD; Wither J; Touma Z
Front Immunol; 2023; 14():1326751. PubMed ID: 38332909
[TBL] [Abstract][Full Text] [Related]
2. Serum S100A8/A9 concentrations are associated with neuropsychiatric involvement in systemic lupus erythematosus: a cross-sectional study.
Zervides KA; Jern A; Nystedt J; Gullstrand B; Nilsson PC; Sundgren PC; Bengtsson AA; Jönsen A
BMC Rheumatol; 2022 Jul; 6(1):38. PubMed ID: 35804434
[TBL] [Abstract][Full Text] [Related]
3. Increased serum levels of S100A8/A9 and S100A12 are associated with cardiovascular disease in patients with inactive systemic lupus erythematosus.
Tydén H; Lood C; Gullstrand B; Jönsen A; Nived O; Sturfelt G; Truedsson L; Ivars F; Leanderson T; Bengtsson AA
Rheumatology (Oxford); 2013 Nov; 52(11):2048-55. PubMed ID: 23942785
[TBL] [Abstract][Full Text] [Related]
4. Pro-inflammatory S100 proteins are associated with glomerulonephritis and anti-dsDNA antibodies in systemic lupus erythematosus.
Tydén H; Lood C; Gullstrand B; Jönsen A; Ivars F; Leanderson T; Bengtsson AA
Lupus; 2017 Feb; 26(2):139-149. PubMed ID: 27407135
[TBL] [Abstract][Full Text] [Related]
5. Phagocyte-specific S100A8/A9 protein levels during disease exacerbations and infections in systemic lupus erythematosus.
Soyfoo MS; Roth J; Vogl T; Pochet R; Decaux G
J Rheumatol; 2009 Oct; 36(10):2190-4. PubMed ID: 19755614
[TBL] [Abstract][Full Text] [Related]
6. Platelet-Derived S100A8/A9 and Cardiovascular Disease in Systemic Lupus Erythematosus.
Lood C; Tydén H; Gullstrand B; Jönsen A; Källberg E; Mörgelin M; Kahn R; Gunnarsson I; Leanderson T; Ivars F; Svenungsson E; Bengtsson AA
Arthritis Rheumatol; 2016 Aug; 68(8):1970-80. PubMed ID: 26946461
[TBL] [Abstract][Full Text] [Related]
7. Protein synthesis of the pro-inflammatory S100A8/A9 complex in plasmacytoid dendritic cells and cell surface S100A8/A9 on leukocyte subpopulations in systemic lupus erythematosus.
Lood C; Stenström M; Tydén H; Gullstrand B; Källberg E; Leanderson T; Truedsson L; Sturfelt G; Ivars F; Bengtsson AA
Arthritis Res Ther; 2011 Apr; 13(2):R60. PubMed ID: 21492422
[TBL] [Abstract][Full Text] [Related]
8. Urine and serum S100A8/A9 and S100A12 associate with active lupus nephritis and may predict response to rituximab treatment.
Davies JC; Midgley A; Carlsson E; Donohue S; Bruce IN; Beresford MW; Hedrich CM
RMD Open; 2020 Jul; 6(2):. PubMed ID: 32723832
[TBL] [Abstract][Full Text] [Related]
9. Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities.
Ainiala H; Hietaharju A; Dastidar P; Loukkola J; Lehtimäki T; Peltola J; Korpela M; Heinonen T; Nikkari ST
Arthritis Rheum; 2004 Mar; 50(3):858-65. PubMed ID: 15022328
[TBL] [Abstract][Full Text] [Related]
10. S100A8/A9 promotes MMP-9 expression in the fibroblasts from cardiac rupture after myocardial infarction by inducing macrophages secreting TNFα.
Shi S; Yi JL
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3925-3935. PubMed ID: 29949169
[TBL] [Abstract][Full Text] [Related]
11. C-reactive protein is a more sensitive and specific marker for diagnosing bacterial infections in systemic lupus erythematosus compared to S100A8/A9 and procalcitonin.
Kim HA; Jeon JY; An JM; Koh BR; Suh CH
J Rheumatol; 2012 Apr; 39(4):728-34. PubMed ID: 22337236
[TBL] [Abstract][Full Text] [Related]
12. S100A8 in Serum, Urine, and Saliva as a Potential Biomarker for Systemic Lupus Erythematosus.
Kim JW; Jung JY; Lee SW; Baek WY; Kim HA; Suh CH
Front Immunol; 2022; 13():886209. PubMed ID: 35529863
[TBL] [Abstract][Full Text] [Related]
13. S100A8/A9, a potent serum and molecular imaging biomarker for synovial inflammation and joint destruction in seronegative experimental arthritis.
Geven EJ; van den Bosch MH; Di Ceglie I; Ascone G; Abdollahi-Roodsaz S; Sloetjes AW; Hermann S; Schäfers M; van de Loo FA; van der Kraan PM; Koenders MI; Foell D; Roth J; Vogl T; van Lent PL
Arthritis Res Ther; 2016 Oct; 18(1):247. PubMed ID: 27776554
[TBL] [Abstract][Full Text] [Related]
14. White matter lesions and brain atrophy in systemic lupus erythematosus patients: correlation to cognitive dysfunction in a cohort of systemic lupus erythematosus patients using different definition models for neuropsychiatric systemic lupus erythematosus.
Cannerfelt B; Nystedt J; Jönsen A; Lätt J; van Westen D; Lilja A; Bengtsson A; Nilsson P; Mårtensson J; Sundgren PC
Lupus; 2018 Jun; 27(7):1140-1149. PubMed ID: 29523054
[TBL] [Abstract][Full Text] [Related]
15. Hydroxychloroquine modulates elevated expression of S100 proteins in systemic lupus erythematosus.
Wakiya R; Kameda T; Ueeda K; Nakashima S; Shimada H; Mansour MF; Kato M; Miyagi T; Miyatake N; Kadowaki N; Dobashi H
Lupus; 2019 Jun; 28(7):826-833. PubMed ID: 31068068
[TBL] [Abstract][Full Text] [Related]
16. Assessing the Utility of the Montreal Cognitive Assessment in Screening for Cognitive Impairment in Patients With Systemic Lupus Erythematosus.
Tayer-Shifman OE; Yuen K; Green R; Kakvan M; Katz P; Bingham KS; Diaz-Martinez JP; Ruttan L; Wither JE; Tartaglia MC; Su J; Bonilla D; Choi MY; Appenzeller S; Barraclough M; Beaton DE; Touma Z
Arthritis Care Res (Hoboken); 2023 Mar; 75(3):569-577. PubMed ID: 35724303
[TBL] [Abstract][Full Text] [Related]
17. Metrics and definitions used in the assessment of cognitive impairment in systemic lupus erythematosus: A systematic review.
Yuen K; Green R; Bingham K; Ruttan L; Lee-Kim V; Tartaglia MC; Anderson M; Zandy M; Choi MY; Fritzler MJ; Wither JE; Beaton DE; Katz P; Touma Z
Semin Arthritis Rheum; 2021 Aug; 51(4):819-830. PubMed ID: 34157577
[TBL] [Abstract][Full Text] [Related]
18. Serum BDNF and cognitive dysfunction in SLE: findings from a cohort of 111 patients.
Alessi H; Dutra LA; Maria LA; Coube PC; Hoshino K; de Abrantes FF; Lopes FC; de Souza AWS; Kayser C; Barsottini OGP
Clin Rheumatol; 2022 Feb; 41(2):421-428. PubMed ID: 34537904
[TBL] [Abstract][Full Text] [Related]
19. Validation of the automated neuropsychological assessment metrics for assessing cognitive impairment in systemic lupus erythematosus.
Yuen K; Beaton D; Bingham K; Katz P; Su J; Diaz Martinez JP; Tartaglia MC; Ruttan L; Wither JE; Kakvan M; Anderson N; Bonilla D; Choi MY; Fritzler MJ; Green R; Touma Z
Lupus; 2022 Jan; 31(1):45-54. PubMed ID: 34957878
[TBL] [Abstract][Full Text] [Related]
20. Correlation between neurofilament, HMGB1, MMP9, ds DNA blood levels and cognitive impairment in patients with neuropsychiatric systemic lupus erythematosus.
Ahmadzade A; Simani L; Roozbeh M; Farsad F; Sheibani M; Negaresh O; Emam MM; Rajaei A; Kazempour M; Ramezani M; Nazarpoor S
Caspian J Intern Med; 2024; 15(1):58-65. PubMed ID: 38463908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
